NFKB1 and neoplasm: In the meantime, interfering with this axis utilizing the NF-κB inhibitor [21,34], the IL-6 receptor antibody [21,35], the Stat3 inhibitor [21,30,36] or down-regulating the expression of Twist [26] reduces the CSC population and results in inhibition of tumor growth and metastasis.